The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
The EGFR signalling system in the liver: from hepatoprotection to hepatocarcinogenesis
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
El-Serag, H. B. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1001683 · Cited by 3,529
Michalopoulos, G. K. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21172 · Cited by 1,384
White, D. L., Kanwal, F., & El–Serag, H. B. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.10.001 · Cited by 766 · cited 1×
“Persistent liver injury due to chronic alcohol consumption, bad dietary habits leading to intrahepatic fat accumulation as well as hepatotropic viral infections resulting in chronic liver injury and cirrhosis, are strongly linked to the development of liver tumors [71–73].”
BackgroundLiver Regeneration after Partial Hepatectomy
Michalopoulos, G. K. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090675 · Cited by 713
Understanding resistance to EGFR inhibitors—impact on future treatment strategies
Wheeler, D. L., Dunn, E. F., & Harari, P. M. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.97 · Cited by 683 · cited 1×
“The resistance mechanisms to EGFR-targeted drugs may operate at various cellular and molecular levels, and many of them have been already characterized in other types of solid tumors [139–142] (Fig.”
BackgroundThe epidermal growth factor receptor ligands at a glance
Schneider, M. R., & Wolf, E. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21635 · Cited by 447
Fibrosis-dependent mechanisms of hepatocarcinogenesis
Zhang, D. Y., & Friedman, S. L. (2012) · Hepatology · doi:10.1002/hep.25670 · Cited by 444 · cited 1×
“These alterations pave the way for the development of HCC, being liver fibrosis a strong determinant for the appearance of liver tumors [80].”
BackgroundThe EGF receptor is required for efficient liver regeneration
Natarajan, A., Wagner, B., & Sibilia, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704126104 · Cited by 320
Fausto, N., Campbell, J. S., & Riehle, K. J. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.04.016 · Cited by 187
Perugorria, M. J., Latasa, M. U., Nicou, A., Cartagena‐Lirola, H., Castillo, J., Goñi, S., Vespasiani‐Gentilucci, U., Zagami, M. G., Lotersztajn, S., Prieto, J., et al. (2008) · Hepatology · doi:10.1002/hep.22437 · Cited by 151 · cited 3×
“Interestingly, AR behaved as a mitogen and pro-survival factor for cultured ECM-producing cells, where it also upregulated CTGF expression [86].”
BackgroundSelf-citation
Cited by
Hepatocellular carcinoma (HCC): beyond sorafenib—chemotherapy
Kim, D. W., Talati, C., & Kim, R. (2017) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2016.09.07 · Cited by 333
Expression and Function of the Epidermal Growth Factor Receptor in Physiology and Disease
Chen, J., Zeng, F., Forrester, S. J., Eguchi, S., Zhang, M.-Z., & Harris, R. C. (2016) · Physiological Reviews · doi:10.1152/physrev.00030.2015 · Cited by 327
López‐Luque, J., Caballero‐Díaz, D., Martinez‐Palacián, A., Roncero, C., Moreno‐Càceres, J., García‐Bravo, M., Grueso, E., Fernández, A., Crosas‐Molist, E., García‐Álvaro, M., et al. (2016) · Hepatology · doi:10.1002/hep.28134 · Cited by 68
“tor receptor (EGFR/ErbB1) pathway plays an essential role in virtually all steps of these processes.(1) However, many questions remain unanswered.”
BackgroundMolecular pathways of liver regeneration: A comprehensive review
Kiseleva, Y. V., Antonyan, S. Z., Zharikova, T. S., Tupikin, K. A., Kalinin, D. V., & Zharikov, Y. O. (2021) · World Journal of Hepatology · doi:10.4254/wjh.v13.i3.270 · Cited by 62
Kim, S. H., Kim, J. Y., Park, S. Y., Jeong, W. T., Kim, J. M., Bae, S. H., & Kim, G. J. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02616-y · Cited by 24
Metadata
- Authors
- Berasain, C., & Avila, M. A.
- Venue
- Journal of Gastroenterology
- Published
- 2013-12-10
- Volume
- 49
- Issue
- 1
- Pages
- 9-23
- ISSN
- 0944-1174 (ISSN-L)
- 1435-5922
- OpenAlex
- W2055049583
- Cited by
- 174
- References
- 10
- FWCI
- 4.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.